Search

A recent study from Semmelweis University in Budapest, Hungary, highlighted the frequent occurrence of NTRK amplifications in pan-TRK immunopositive dedifferentiated liposarcomas. The research focused on detecting tumors with or without NTRK gene alterations using the Pan-TRK antibody and found a positive correlation between pan-TRK immunoreaction and NTRK status. The study concluded that NTRK amplifications may play a crucial role in TRK inhibition therapy for liposarcomas. [Extracted from the article]

A recent study conducted at Ohio State University focused on the use of three-dimensional (3D) cell culture models, specifically Patient-Derived Organoids (PDOs), to advance research on liposarcomas, a rare type of soft tissue sarcoma. The research highlighted the limitations of traditional 2D cell culture and in vivo mouse models in studying liposarcomas, emphasizing the potential of 3D cell culture techniques to bridge this gap. The study, supported by the United States Department of Defense, explored the current and future applications of PDOs in investigating the molecular mechanisms and developing effective therapies for liposarcomas. [Extracted from the article]

A patent application titled "Treatment Of Myxoid/Round Cell Liposarcoma Patients" by inventor Glen J. Weiss and assigned to Sotio Biotech Inc. discusses the use of Glypican 3 (GPC3) as a diagnostic biomarker and treatment target for myxoid/round cell liposarcoma (MRCLS). The method involves administering an anti-GPC3 therapeutic agent to patients diagnosed with MRCLS, with specific criteria for patient selection and treatment. The therapeutic agent may include genetically engineered hematopoietic cells expressing an anti-GPC3 chimeric receptor polypeptide, among other options. This patent application aims to address the need for new therapy options for MRCLS, a high-medical need indication. [Extracted from the article]

Researchers at the Homi Bhabha Cancer Hospital and Research Centre in Bihar, India, have published a case report on a rare neck liposarcoma of dedifferentiated type. The report highlights the challenges associated with diagnosing and treating this life-threatening malignancy, emphasizing the importance of imaging, histopathological, and immunohistochemical expertise. The 54-year-old male patient in the case study underwent wide excision of the neck mass followed by adjuvant radiotherapy and has been disease-free for 1.5 years. This research provides valuable insights into the surgical management and histological features of this variant of liposarcoma. [Extracted from the article]

Researchers from Peking University Third Hospital conducted a study on using a preoperative contrast-enhanced CT-based deep learning radiomics model to distinguish between retroperitoneal well-differentiated liposarcomas and lipomas. The study included 167 patients and showed that the model had good performance in predicting the distinction between the two conditions. The research concluded that the model could be a promising imaging biomarker for personalized management and precision medicine. [Extracted from the article]

A recent study conducted at Ohio State University Wexner Medical Center focused on the oncogenic functions of the alternatively spliced MDM2-ALT2 isoform in retroperitoneal liposarcoma (RPLPS). The research highlighted the upregulation of MDM2-ALT2 expression levels in RPLPS patient-derived tissue samples compared to normal adjacent to tumor tissue. The study concluded that MDM2-ALT2 may promote RPLPS progression by increasing proliferation rates, migration, and invasion capacities in DDLPS cell lines. For more information, the full article can be accessed through the International Journal of Molecular Sciences. [Extracted from the article]

The article discusses a case report of a 51-year-old man with metastatic dedifferentiated liposarcoma of the mediastinum with osteosarcomatous differentiation. Initially misdiagnosed as a teratoma, the patient underwent surgical excision and postoperative chemotherapy, but unfortunately experienced mediastinal recurrences and chest wall metastases leading to death. The research emphasizes the importance of correct diagnosis for appropriate therapy choices and highlights the need for clinicians to be aware of rare presentations of liposarcomas for effective treatment strategies. [Extracted from the article]

A recent study from the University of Miami delves into the epidemiology, diagnosis, pathophysiology, and treatment limitations of liposarcomas, a rare type of tumor that affects soft tissue. Liposarcomas are classified into four subtypes, with well-differentiated liposarcoma being the most common. Diagnosis of sarcomas is challenging due to their rarity and complexity, leading to misdiagnoses in approximately 30% of cases. Treatment options for liposarcomas are limited, highlighting the need for further research and clinical trials in this area. [Extracted from the article]

Researchers at the General Hospital of Ningxia Medical University in China published a case report and literature review on dedifferentiated recurrent liposarcoma of the uterine corpus, highlighting the unique histopathologic characteristics and management challenges of this rare tumor. The study focused on a 57-year-old patient who underwent multiple surgeries and chemotherapy for recurrent liposarcoma, emphasizing the aggressive nature of the disease and the importance of tailored management strategies. The research underscores the need for further understanding and treatment options for dedifferentiated liposarcoma. [Extracted from the article]

A recent study conducted at Ohio State University Medical Center focused on targeted transcriptomic analysis of well-differentiated and dedifferentiated liposarcoma, revealing dysregulated pathways such as glucose metabolism, TGF-b, and HIF-1 signaling. The research highlighted the need for identifying potential therapeutic targets for the treatment of this disease, particularly in the context of sparing multi-visceral removal through radical surgical resection. The findings suggest a possible proinflammatory tumor environment within well-differentiated liposarcoma and activation of the TGF-b signaling pathway. For more information, readers can access the full article in Frontiers in Oncology. [Extracted from the article]

A recent study conducted at Government Medical College in South Gujarat reported on a rare case of giant intraabdominal liposarcomatosis, a malignant tumor of mesenchymal origin. The study focused on a 45-year-old hypertensive female who presented with a diffuse abdominal lump and vague pain, leading to the diagnosis of Well-Differentiated Liposarcoma-FNCLCC Grade 1. The patient underwent successful surgery with no signs of recurrence after six months of follow-up. This research provides valuable insights into the diagnosis and management of liposarcomas in clinical practice. [Extracted from the article]

A recent study published in the International Journal of Surgical Pathology reported on a 55-year-old woman with a primary liposarcoma of the spleen, a rare occurrence. The researchers conducted an open splenectomy and found MDM2-amplification in all tumor cells, indicating a diagnosis of well-differentiated liposarcoma confined to the spleen. This case represents the first description of a primary liposarcoma of the spleen in the literature, highlighting the importance of long-term follow-up due to the risk of local recurrence. For more information, readers can access the full article through the provided link. [Extracted from the article]

A study conducted at University Hospital Jena in Germany focused on a rare case of primary dedifferentiated liposarcoma of the thoracic spine in a 36-year-old woman. The patient underwent surgery, chemotherapy, and radiation therapy, followed by structured tumor aftercare, resulting in a tumor- and metastasis-free status 53 months after treatment. The research emphasizes the importance of specialized sarcoma centers for individualized treatment options and interdisciplinary aftercare to achieve the best possible outcomes for patients with primary sarcomas of the spine. [Extracted from the article]

Researchers at Saitama Medical University International Medical Center have published a case report on a rare clinical presentation of dedifferentiated liposarcoma showing a leiomyosarcoma phenotype in the ileocecal region. The study highlights the importance of accurate diagnosis in cases of dedifferentiated liposarcoma, as treatment strategies may differ significantly from other soft tissue sarcomas. The research emphasizes the need for further investigation and clinical trials to improve outcomes for patients with this rare form of cancer. [Extracted from the article]

A recent report from researchers at the First Hospital of Jilin University in Changchun, China, focused on a rare case of dedifferentiated liposarcoma originating in the gallbladder. The study detailed the diagnosis and treatment of a 64-year-old female patient who underwent surgery to remove the tumor and gallbladder. The researchers highlighted the challenges in treating dedifferentiated liposarcoma and emphasized the importance of radical resection as the current treatment of choice. Further research is needed to explore potential future treatments such as radiotherapy and chemotherapy. [Extracted from the article]

A study conducted at Hospital Metropolitano focused on dysphagia caused by esophageal liposarcoma, a rare condition with nonspecific symptoms. The case of a 70-year-old male who initially refused treatment due to fear but later underwent surgery after experiencing severe complications was highlighted. The research emphasized the importance of complete resection for improved prognosis and prevention of complex complications. For more information, the study "Progressive dysphagia from an esophageal liposarcoma, a complex problem in a challenging setting" can be accessed in the Journal of Surgical Case Reports. [Extracted from the article]

Researchers at Ibn Sina University Hospital reported a rare case of a 52-year-old man diagnosed with both retroperitoneal liposarcoma and gastric adenocarcinoma, marking only the second reported case worldwide. The simultaneous occurrence of these two malignancies is extremely uncommon, with liposarcoma being a rare malignancy arising from adipose tissue and gastric adenocarcinoma being one of the most common neoplasms globally. This research sheds light on the potential for multiple primary malignancies to occur synchronously in adults, highlighting the importance of further study in this area. [Extracted from the article]

Researchers at Semmelweis University in Budapest, Hungary, have identified a recurrent NTRK1 tyrosine kinase domain mutation pair in a subset of dedifferentiated liposarcomas. This mutation pair, c.1810C >T (p.H604Y) and c.1838G >T (p.G613V), was found in six cases and is associated with resistance to TRK inhibitors. The study suggests that these mutations may be a biomarker for further research on TRK inhibitors in treating liposarcomas. The findings were published in the European Journal of Cancer and have been peer-reviewed. [Extracted from the article]

A recent report from Adventist Hinsdale Hospital in Illinois discusses a case of a 72-year-old man with a chest wall lesion initially misdiagnosed as a local infection, which was later identified as a rare combination of inflammatory myofibroblastic tumor and liposarcoma. The patient underwent successful resection and is currently doing well with over 4 years of follow-up. This study sheds light on the challenges of diagnosing and treating uncommon tumors like liposarcomas, emphasizing the importance of accurate and timely diagnosis in improving patient outcomes. [Extracted from the article]

A recent study from Xiamen University examined the impact of intraoperative radiotherapy (IORT) on retroperitoneal liposarcoma patients. The research, based on a population-based propensity score-matched study, found that there was no significant difference in overall survival between patients who received IORT and those who did not. The study suggests that IORT may not provide additional benefits for patients with retroperitoneal liposarcoma, highlighting the need for further prospective clinical studies in this area. For more information, the full article can be accessed for free at the Frontiers in Oncology website. [Extracted from the article]

A recent study conducted at the First People's Hospital focused on primary mediastinal liposarcomas (PLMs), a rare form of cancer that can cause symptoms due to the compression of surrounding tissues and organs. The study presented a case of successful thoracoscopic resection of a large PLM in a 38-year-old male patient, resulting in improved symptoms postoperatively. The research highlighted the challenges and risks associated with surgical resection of PLMs due to the proximity of vital structures, emphasizing the importance of careful preservation of surrounding organs during minimally invasive procedures. [Extracted from the article]

A recent study conducted at Seoul National University Hospital focused on dedifferentiated liposarcoma of the extremities (DDL-E), a rare form of cancer. The study analyzed 107 cases and found that localized DDL-E has a low potential for metastasis and carries an excellent prognosis. The research highlighted the importance of close monitoring for other primary malignancies and extrapulmonary metastasis in DDL-E patients, and suggested further investigation into surgical approaches for resection margins. [Extracted from the article]

A patent application titled "Methods For The Treatment Of Cancer" was published online by inventors from France. The application focuses on targeting the recruitment of MDM2 to chromatin in cancer cells, particularly liposarcoma, using Interleukin-6 (IL-6) signaling inhibitors to induce cancer cell death. The method involves administering IL-6 inhibitors to subjects with cancer exhibiting MDM2 recruitment to chromatin, potentially leading to more effective cancer treatments. This patent application aims to address the need for new pharmaceutical compositions and methods to treat and prevent cancers with MDM2 recruitment to chromatin, offering innovative approaches to combat these complex types of cancer. [Extracted from the article]

A recent study conducted by researchers at Xiamen University in China aimed to identify common therapeutic targets for well-differentiated and dedifferentiated retroperitoneal liposarcoma. The study utilized patient clinical data from the SEER database and gene expression data from the GEO dataset to identify key hub genes and transcription factors associated with the two types of liposarcoma. The research highlighted the importance of lipid localization, storage, cytokine signaling, and metal ion absorption in both subtypes, and successfully predicted four potential therapeutic drugs. This study provides new insights into potential therapeutic development for retroperitoneal liposarcoma. [Extracted from the article]

Researchers at Henan University conducted a study on liposarcomas, the second most common type of soft tissue sarcoma. They focused on the prognostic and therapeutic significance of BAG1 and BAG2 as potential biomarkers for predicting survival outcomes in liposarcoma patients. The study found that high BAG2 expression and/or low BAG1 expression were associated with worse prognosis, and these genes may serve as potential therapy targets for liposarcomas. The research highlights the importance of BAG1 and BAG2 in liposarcomagenesis and immune infiltration, offering insights into personalized treatment approaches for this type of cancer. [Extracted from the article]

Researchers at the Osaka International Cancer Institute conducted a study on the efficacy of surgery in managing multiple recurrences of retroperitoneal dedifferentiated liposarcoma. The study found that initial and second surgeries significantly improved overall survival rates, regardless of malignancy level, but no significant improvement was observed after the third surgery. The research emphasizes the importance of considering tumor malignancy level and patient condition when deciding on repeated surgical interventions for patients with recurrent liposarcoma. The study suggests that surgical treatment can prolong overall survival, especially in cases of recurrence, but it is crucial to assess malignancy levels before deciding on surgery beyond the second recurrence. [Extracted from the article]

A recent study conducted by researchers from the University of Montreal Health Center examined the impact of surgical resection on cancer-specific mortality (CSM) in soft tissue pelvic sarcoma. The study analyzed data from the Surveillance, Epidemiology, and End Results (SEER) database and identified 2491 patients diagnosed with pelvic soft tissue sarcoma. The results showed that surgical resection was associated with a reduction in CSM in non-metastatic soft tissue pelvic sarcoma, particularly for patients with liposarcoma and leiomyosarcoma. However, the protective effect of surgical resection was limited to patients with leiomyosarcoma in the metastatic stage. This study provides valuable insights into the association between surgical resection and CSM in different histologic subtypes and stages of soft tissue sarcoma. [Extracted from the article]

A new report from the University of Texas MD Anderson Cancer Center presents fresh data on liposarcomas, a type of cancer. The study aimed to evaluate the predictive features of baseline F-18-fluorodeoxy-D-glucose positron emission tomography (18F-FDG PET)/computed tomography (CT) parameters in patients with dedifferentiated liposarcomas (DDLPSs) and well-differentiated liposarcomas (WDLPSs) receiving systemic treatment. The researchers found that the ratios of certain SUV/HU parameters at baseline were significant indicators of treatment response in patients with liposarcoma. This study introduces baseline SUV/HU ratios as a valuable diagnostic tool in predicting liposarcoma treatment outcomes. [Extracted from the article]

A recent study conducted by researchers at the School of Medicine aimed to understand the tolerability and outcomes of treatment for older patients with myxoid liposarcoma, a type of cancer that primarily affects young and middle-aged individuals. The study included 16 patients aged 70 years and older with localized myxoid liposarcoma. The majority of patients received perioperative radiation therapy with surgery, and few serious toxicities were reported. However, half of the patients experienced relapse even with treatment. The study provides valuable insights into the treatment of older patients with myxoid liposarcoma. [Extracted from the article]

This article discusses a study on liposarcomas, a type of rare tumor derived from mesenchymal tissues. The researchers focused on the differentiation status of liposarcomas and its impact on prognosis and metastasis. They found that overexpression of the Hedgehog transcription factor Gli2 in dedifferentiated liposarcoma cells repressed adipogenic differentiation and activated markers of osteoblast differentiation. Additionally, they observed changes in cytokine expression and an increase in M2-like macrophages in orthotopic fat pad injections of Gli2 overexpressing cells. This study highlights the role of Gli2 in liposarcoma pathogenesis and suggests it as a potential target for therapeutic interventions. [Extracted from the article]

A recent study conducted at Fudan University in Shanghai, China, explored the prognostic value of F-18-FDG PET/CT imaging in predicting the recurrence of retroperitoneal liposarcoma (RPLPS). The study analyzed the characteristics of different histologic subtypes of RPLPS and their associations with recurrence and prognosis. The researchers found that certain SUV and CT features on F-18-FDG PET/CT imaging can increase confidence in subtype diagnosis and predict recurrence. Patients with higher SUVmax and SUVpeak values were found to have a poor prognosis. This study provides new insights into the management of RPLPS and may help guide treatment decisions. [Extracted from the article]

A study conducted at Peking University Cancer Hospital and Institute in Beijing, China, evaluated the effectiveness of a combined therapeutic strategy using eribulin, anlotinib, and camrelizumab in treating advanced or metastatic retroperitoneal liposarcoma (RLPS). The study included 47 patients with RLPS, and the treatment regimen resulted in a partial response in 18.2% of patients and stable disease in 56.8% of patients. The median progression-free survival was 6.9 months, and the treatment showed promising efficacy and manageable safety, particularly in patients with myxoid liposarcoma. This research provides valuable insights into potential treatment options for RLPS. [Extracted from the article]

A recent study conducted at the Mayo Clinic in Rochester, Minnesota, focused on liposarcomas, a type of cancer known for its tendency to spread beyond the lungs. The researchers presented a case of a 62-year-old man with an oligometastatic myxoid liposarcoma (MLPS) that had spread to the heart. Instead of surgical removal, the patient's metastatic mass was successfully managed with a combination of chemotherapy and radiotherapy, resulting in stable disease for over 10 years. The study challenges the belief that surgery is the only effective treatment for recurrent sarcomas and highlights the importance of aggressive management with chemotherapy and radiotherapy for chemosensitive and radiosensitive sarcomas. [Extracted from the article]

A case report from Mansoura University discusses the presentation and management of liposarcoma, a type of cancer, in the spermatic cord. Liposarcoma is the most common type of sarcoma in the spermatic cord and typically presents as a progressively enlarging mass in the inguinoscrotal area. The report describes a unique case of metastatic liposarcoma in a 53-year-old male with scrotal swelling. The primary tumor was surgically removed, and the patient underwent adjuvant chemotherapy and follow-up. The study highlights the importance of considering liposarcoma in the differential diagnosis of inguinoscrotal lesions, even in the absence of typical imaging features. [Extracted from the article]

A recent study conducted at Aleppo University Hospital in Syria focused on a rare case of renal retroperitoneal liposarcoma, a type of tumor that arises from mesenchymal cells in the peritoneum cavity. The study aimed to raise awareness about this rare tumor and describe its major concepts. The case involved a 44-year-old woman who presented with hirsutism and irregular menstruation, and was found to have a large abdominal mass. After undergoing surgical removal, the patient's symptoms disappeared. Retroperitoneal liposarcomas can occasionally arise near the kidney and compress the adjoining adrenal gland. [Extracted from the article]

A study conducted by researchers at the University of Pisa in Italy provides new insights into the treatment of myxoid liposarcomas, a type of malignant soft-tissue sarcoma. The study analyzed cases of myxoid liposarcomas of the thigh that were treated with surgical resection between 2016 and 2022. The researchers found that the quality of resection margins influenced the rate of local recurrence, while tumor grade influenced the risk of metastases. Adequate surgery was associated with good post-operative functional outcomes. The findings highlight the challenges and outcomes associated with the treatment of myxoid liposarcomas. [Extracted from the article]

The article discusses new research from the University of California Los Angeles (UCLA) on targeting asparagine metabolism to inhibit tumor growth in well-differentiated and dedifferentiated liposarcoma. Topics discussed include the role of asparagine in mTORC1 signaling, the effectiveness of combining electron transport chain inhibitors with asparagine-free media and PEGylated L-Asparaginase (PEG-Asnase), and the impact of these treatments on cell proliferation and tumor growth.